Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter studyCOVID-19로 입원 한 환자를위한 덱사메타손과 함께 Remdesivir : 후 향적 다기관 연구Multicenter Study Published on 2022-02-172022-09-10 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 치료제, [키워드] 1:1 addition Admission Algorithm analyzed balance checked clinical benefit Combination COVID-19 pneumonia death death rate death rates Dexamethasone duration of hospitalization Hospital mortality Hospitalization hospitalized patient hospitalized patients In-hospital death in-hospital mortality Infectious disease Infectious diseases intensive care intensive care unit Logistic low-flow oxygen male Male sex matching mean differences median median time multivariable outcome oxygen Patient patients hospitalized patients with COVID-19 Pneumonia populations Primary outcome prognostic Propensity score receiving reduced Remdesivir replacement Result retrospective cohort study Retrospective multicenter study secondary Secondary outcomes Standard deviation Standard of care symptoms onset transfer Treatment was performed with COVID-19 [DOI] 10.1371/journal.pone.0262564 PMC 바로가기 [Article Type] Multicenter Study
Hospital factor and prognosis of COVID-19 in New York City, the United States of America: insights from a retrospective cohort studyResearch Published on 2022-02-082022-10-28 Journal: BMC health services research [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] 95% confidence interval adjust Analysis baseline characteristics Brooklyn cohort study Community community hospital Coronavirus disease 2019 COVID-19 death rate Factor hazard ratio hospital Hospital factor hospitalized patient hospitals Laboratory Manhattan medical record Mortality Mount Sinai New York City pandemic Patient patients presenting Probability Prognosis Propensity score Result retrospective cohort study supplementary material System Teaching hospital the United State transfer transferred Treatment was performed Weighting [DOI] 10.1186/s12913-022-07570-w PMC 바로가기 [Article Type] Research
High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysisArticle Published on 2022-02-012023-06-12 Journal: Expert review of gastroenterology & hepatology [Category] B형 간염, [키워드] Chemoembolization cirrhosis Hepatocellular carcinoma Platelet Propensity score [DOI] 10.1080/17474124.2022.2031977
Hemodialysis patients with coronavirus disease 2019: reduced antibody response2019년 코로나바이러스 질환 혈액투석 환자: 항체 반응 감소Article Published on 2022-02-012022-09-11 Journal: Clinical and experimental nephrology [Category] COVID19(2023년), MERS, SARS, 바이오마커, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus antibody antibody production Antibody Response Antibody testing balance coronavirus coronavirus disease Coronavirus disease 2019 covariate COVID-19 COVID-19 patient detect disease distribution Hemodialysis higher risk hospitalized patient hospitalized patients iFlash IgG antibodies IgG antibody immune response Immunoglobulin increased risk Maintenance hemodialysis non-severe patients Pathogens Patient patients patients with COVID-19 performed produced Propensity score propensity score matching quantified reduced respiratory retrospective cohort study S1 subunit SARS-CoV-2 severe coronavirus disease severe COVID-19 severe disease Shenzhen significantly lower Spike protein symptom onset symptomatic symptomatic COVID-19 the disease the median the S1 subunit the spike protein was performed was used [DOI] 10.1007/s10157-021-02130-8 PMC 바로가기 [Article Type] Article
Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort1차 유행에서 초기 인터페론-β 치료가 COVID-19 환자의 예후에 미치는 영향: 다기관 코호트의 사후 분석Multicenter Study Published on 2022-02-012022-09-11 Journal: Biomedicine & pharmacotherapy = Biomédecine & phar [Category] COVID19(2023년), SARS, 비임상, 신약개발, 치료법, 치료제, [키워드] 30-Day mortality 95% CI administration Admission all-cause mortality Analysis analyzed antiviral activity association calculated clinical trials Cohort cohort analysis conducted confounder confounders COVID-19 COVID-19 patients Cox regression defined First wave Hospital admission identify Impact in vitro interferon Interferon-β Logistic lower mortality Mortality multicenter multivariate pandemic Patient patients hospitalized primary endpoint prognosis of patient Propensity score receiving Research SARS-CoV-2 Stage subcutaneous administration subgroups of patient the disease therapy Treatment variable with COVID-19 [DOI] 10.1016/j.biopha.2021.112572 PMC 바로가기 [Article Type] Multicenter Study
Trends and Factors Associated With Risk Perception, Anxiety, and Behavior From the Early Outbreak Period to the Controlled Period of COVID-19 Epidemic: Four Cross-Sectional Online Surveys in China in 2020Public Health Published on 2022-01-182022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, SARS, [키워드] accompanied adjust adopted age Anxiety anxiety level approach association baseline characteristics Behavior changes in China collected conducted Controlled convenience COVID-19 COVID-19 epidemic COVID-19 pandemic cross-sectional cross-sectional study design cross-sectional survey declined demographic factor develop dropped Epidemic examined Factor First wave general linear model Health status higher risk identify inclusion criteria independent information Internet Mask meet men online questionnaire outbreak participant Perceived Perceived risk Perception Period positive Propensity score proportion Protective protective behavior Psychological questionnaire receive rising risk Risk perception significantly stages STAI survey trend was used WeChat Wilcoxon signed rank [DOI] 10.3389/fpubh.2021.768867 PMC 바로가기 [Article Type] Public Health
COVID-19 is associated with higher risk of venous thrombosis, but not arterial thrombosis, compared with influenza: Insights from a large US cohortResearch Article Published on 2022-01-122022-10-28 Journal: PLoS ONE [Category] COVID-19, [키워드] 95% CI adjusted Analysis antithrombotic therapy calculated Coagulation Cohort COVID-19 COVID-19 patient Cox proportional hazard dataset demonstrated diagnosed diagnosed with COVID-19 diagnosis of COVID-19 DVT EHR evaluated hazard ratio Health higher risk HRs identify independent Influenza insight knowledge median age medication Myocardial infarction outcome Patient patients with COVID-19 Propensity score Result retrospective retrospective cohort risk SARS-CoV-2 SARS-COV-2 infection secondary secondary outcome stroke Thromboembolic event thromboembolic risk thrombosis variables venous thromboembolic Venous thrombosis were assessed women [DOI] 10.1371/journal.pone.0261786 PMC 바로가기 [Article Type] Research Article
Sustained inflammation, coagulation activation and elevated endothelin-1 levels without macrovascular dysfunction at 3 months after COVID-19Research article Published on 2022-01-012022-10-05 Journal: Thrombosis research [Category] SARS, 바이오마커, [키워드] Activation acute COVID-19 acute phase Alpha 1 antitrypsin baseline C1 esterase inhibitor C1inhC1 esterase inhibitor CARCarotid Artery Reactivity Cardiovascular health carotid Carotid Artery Reactivity caused CIconfidence interval Coagulation Cohort cohort study complexes Concentration conducted confidence interval Contact Control controls Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19coronavirus disease 2019 cytokine level dysfunction Effect elevated ELISAEnzyme-linked immunosorbent assay Endothelial cell Endothelial dysfunction Endothelin-1 enzyme-linked immunosorbent assay ET-1Endothelin-1 Evidence Factor FFactor Follow-up highlight IL-6 ILInterleukin Inflammation Inflammatory cytokine information interleukin Kallikrein material NLRP3Nod-like receptor family pyrin domain containing 3 Nod-like receptor family pyrin domain containing 3 not differ Patient PCRpolymerase chain reaction PKaKallikrein polymerase chain reaction Prevalence Propensity score propensity score matching PSMPropensity Score Matching RDRisk Difference recovered patients Result risk difference SARS-CoV-2 SARS-CoV-2severe acute respiratory syndrome coronavirus 2 SDStandard deviation severe acute respiratory syndrome coronavirus 2 significantly higher SMDStandardized Mean Differences Standard deviation Standardized Mean Differences subject sustained TATThrombin:Antithrombin the WHO Thrombin:Antithrombin thrombosis vascular inflammation Von Willebrand Factor:Antigen VWF:AgVon Willebrand Factor:Antigen were measured WHOWorld Health Organization World Health Organization α1ATalpha 1 antitrypsin [DOI] 10.1016/j.thromres.2021.11.027 [Article Type] Research article
Use of DPP4i reduced odds of clinical deterioration and hyperinflammatory syndrome in COVID-19 patients with type 2 diabetes: Propensity score analysis of a territory-wide cohort in Hong KongResearch article Published on 2022-01-012022-10-05 Journal: Diabetes & metabolism [Category] SARS, 신약개발, [키워드] 95% confidence interval 95%CI Admission Analysis antibody association Clinical deterioration Clinical improvement clinical status Cohort coronavirus 2 COVID-19 COVID-19 patient Diabetes Mellitus Dipeptidyl peptidase-4 DPP4i Evidence exposure Hong Kong Hospitalization Hyperinflammatory syndrome IgG IgG antibody Immunoglobulin G In-hospital death in-hospital mortality Inflammation inhibitor Invasive mechanical ventilation lack Linear regression model Logistic Odds ratio outcome outcomes Patient performed positive Prevent Prognosis Propensity score proportion Prospective reduce reduced respiratory Result SARS-CoV-2 suggested Type viral clearance Viral load with COVID-19 [DOI] 10.1016/j.diabet.2021.101307 [Article Type] Research article
Comparison of 30-day case-fatality rate between dialysis and transplant Covid-19 patients: a propensity score matched cohort studyArticle Published on 2022-01-012023-06-19 Journal: Journal of Nephrology [Category] MERS, SARS, [키워드] COVID-19 Kidney transplantation Propensity score Renal Dialysis [DOI] 10.1007/s40620-021-01172-1 PMC 바로가기